Results 151 to 160 of about 78,018 (293)

A Rare Case of De Novo Acute Myeloid Leukemia, Featuring a <i>KMT2A</i> (<i>MLL</i>) Amplification. [PDF]

Diagnostics (Basel)
Hassan F, Chen J, Westphal C, Tirado CA.
europepmc   +1 more source

1163. Heterotheca camporum (Greene) Shinners

Curtis's Botanical Magazine, EarlyView.
Summary Heterotheca camporum (Greene) Shinners (Compositae: Astereae: Chrysopsidinae) is described and illustrated. Notes are provided for the species' cultivation, propagation, likely pests and diseases, and availability. A full synonymy is given, along with type citations and known presence of type material, together with relevant notes.
Nicholas Hind, Christabel King
wiley   +1 more source

Disease Stage-Dependent Clinical Impact of <i>CTLA4</i> Polymorphism in Multiple Myeloma Treated with Autologous Stem Cell Transplantation. [PDF]

Cancers (Basel)
Horum P, Seipel K, Shaforostova I, Bertschinger M, Bacher U, Pabst T.   +5 more
europepmc   +1 more source

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia

, 2012
Alison Walker, Guido Marcucci
openalex   +2 more sources

Cytogenetic studies of antLinepithema humileShattuck (=Iridomyrmex humilisMayr) in European populations [PDF]

, 1996
Pedro Lorite, Eduardo J. Chica, Teresa Palomeque   +2 more
openalex   +1 more source

Immune‐related toxicity profile after haematopoietic stem cell transplantation in patients with B‐ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab

British Journal of Haematology, EarlyView.
Olayinka Okeleji, David McCall, Branko Cuglievan, Amber Gibson, Demetrios Petropoulos, Priti Tewari, Jeremy Connors, Irtiza N. Sheikh   +7 more
wiley   +1 more source

Rate of MGUS Progression to Haematological Malignancies: A Systematic Review

European Journal of Haematology, EarlyView.
ABSTRACT Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic pre‐cancerous condition that precedes plasma cell dyscrasias, including multiple myeloma (MM). Current clinical guidelines report that MGUS's rate of malignant progression to haematological malignancy (HM) is ~1% per year; however, reported rates have varied widely ...
Stephen James Quinn, Chris Cardwell, Lesley Ann Anderson, Charlene McShane   +3 more
wiley   +1 more source

Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial. [PDF]

Blood Neoplasia
Foran JM, Sun Z, Luger SM, Claxton DF, Lazarus HM, Arber DA, Rowe JM, Paietta E, Racevskis J, Garrett-Bakelman F, Zhang Y, Altman JK, Al-Kali A, Zheng H, Pratz KW, Broun ER, Powell BL, O'Dwyer KM, Godwin JE, Ofran Y, Litzow MR, Tallman MS.   +21 more
europepmc   +1 more source

Cytogenetics of a spontaneous desynaptic mutant in chillies (Capsicum annuum L.).

, 1983
K. G. Raja Rao, O. Aniel Kumar
openalex   +2 more sources

Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis‐Requiring Severe Renal Impairment

European Journal of Haematology, EarlyView.
ABSTRACT Background Severe renal insufficiency requiring dialysis in newly diagnosed multiple myeloma (NDMM) patients has been independently associated with poor survival outcomes. However, there is a paucity of data on factors predicting renal recovery and survival outcomes of these patients.
Rintu Sharma, Eshetu G. Atenafu, Esther Masih‐Khan, Harjot Vohra, Sita Bhella, Christine Chen, Vishal Kukreti, Guido Lancman, Anca Prica, A. Keith Stewart, Rodger Tiedemann, Suzanne Trudel, Chloe Yang, Donna Reece   +13 more
wiley   +1 more source